Atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers

Why the ADAURA study is a big step forward for NSCLC

Lung cancer updates from ASCO 2020

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC

Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma

Novel immunotherapy approaches for small cell lung cancer

KEYNOTE-427 updates: First-line pembrolizumab monotherapy in patients with advanced clear cell renal cell carcinoma

Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab

Renal cell cancer: Highlights from ASCO 2020

FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advanced renal cell carcinoma

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk